logo
Dealing with hair loss? Save 15% on the doctor-developed treatment that boosts new growth: 'The ONLY thing that has helped my hair loss!'

Dealing with hair loss? Save 15% on the doctor-developed treatment that boosts new growth: 'The ONLY thing that has helped my hair loss!'

Daily Mail​03-06-2025
If hair loss has you struggling with your confidence and frustrated with a lack of effective solutions, it may be time to direct your attention to KilgourMD.
The plant-based treatment system takes a multifaceted approach to diminishing hair by both stopping existing loss and stimulating new growth. With the KilgourMD Bundle, you can rely on both the Prevention Scalp Serum and Treatment Scalp Serum to leave your hair fuller and healthier with regular use.
KilgourMD Bundle
Take a multifaceted approach to hair loss with this powerful duo that is formulated to stimulate new growth while soothing your scalp.
Packed with soothing plant-based ingredients, the products were found in a clinical trial to be even more effective than minoxidil.
When you order today, you'll receive both products for an impressive 15 percent off. It's the perfect opportunity to boost your hair growth and your confidence!
Save 15% Shop
It's an excellent opportunity to save 15 percent on two full-size KilgourMD products. Purchased separately, they retail for $78 each. You'll get both for just $150 in this conveniently packaged bundle.
The idea is that by using both products, you can take a more proactive stance against hair loss. The first step in the system is the Prevention Scalp Serum, which is formulated to nourish the scalp while minimizing the chances of further loss.
It works by blocking DHT production, which is the hormone responsible for thinning the hair over time. At the same time, it can minimize damages linked to common hair loss culprits like environmental stressors and age.
In a clinical trial, it was found to be even more effective than minoxidil when used with the brand's Treatment Scalp Serum (also included in the bundle).
That's an impressive showing, as minoxidil is widely considered a first line of defense against hair loss. However, it can come with a slew of unwelcome side effects that make it difficult to continue with treatment.
KilgourMD 's approach is far more soothing. The plant-based medley is formulated to minimize the effects of 'inflammaging' on the scalp while protecting it from irritants like ultraviolet damage.
The second product in the bundle, the Treatment Scalp Serum, is formulated to restore hair to sparse spots and leave hair looking and feeling thicker and fuller.
Its hero ingredient, Redensyl®, works alongside a cocktail of botanical ingredients to reduce inflammation, boost antioxidant protection, and stimulate new growth by reviving blood flow to the follicles.
Shoppers are thrilled with the results, stating that the duo has made an enormous difference while giving them a big confidence increase.
'I felt like I was losing clumps every time I showered,' said one. 'This serum has truly helped get my hair back on track. I've been using it for about two months, and I'm seeing real regrowth. It's the only thing that has helped my postpartum hair loss!'
Another commented, 'A game-changer for my hair. This serum is the first thing that's actually made a noticeable difference. My hair feels thicker, and I'm shedding way less.'
'My hairline is coming back!' exclaims a third. 'I've been consistent with it for about 10 weeks now, and I can see new growth along my temples. Definitely going to keep using this.'
Give your scalp the TLC it deserves — and see the difference the KilgourMD Bundle can make to your hair's condition. Snap it up now to save 15 percent!
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Messi's Miami in Leagues Cup quarters as new format fuels goals, ratings surge
Messi's Miami in Leagues Cup quarters as new format fuels goals, ratings surge

Reuters

timean hour ago

  • Reuters

Messi's Miami in Leagues Cup quarters as new format fuels goals, ratings surge

Aug 20 (Reuters) - The Leagues Cup 2025 has reached its quarter-final stage, with four enticing MLS-Liga MX matchups set for Wednesday, showcasing the tournament's revamped format that has seen more goals and boosted commercial interest and fan engagement. Lionel Messi's Inter Miami headline the quarter-final contenders, while Mexican powerhouse Tigres UANL and MLS outfit Seattle Sounders are also among the favourites heading into the last eight. Through Phase One of the tournament, average match viewership reached 1.43 million, up 62% from 2024, across MLS Season Pass, Apple TV+, linear broadcasters in North America, and third-party platforms, organisers told Reuters on Wednesday. Corporate sponsor revenue is up 13% year-on-year, with Walmart and Ocean Spray added as new partners. Digital and social media consumption has also risen sharply, organisers said. On the pitch, the absence of draws and penalty shootouts following 90 minutes has led to an average of 3.37 goals per game. This figure surpasses regular-season scoring rates in MLS, Liga MX and several leading European leagues, according to organisers. "It really starts with the competition and this new format," Leagues Cup executive director Thomas Mayo told Reuters. "The level of play is very high. They're all arm in arm at the penalty shootouts and there's some real emotion. It means a lot to them. It's a tough competition." This year's tournament features all 18 Liga MX teams and 18 qualifying MLS teams and the four quarter-finals will pit MLS clubs against Liga MX opponents, reinforcing the cross-border rivalry at the heart of the competition's redesign. Matches between the two leagues have been closely contested, with points shared evenly between MLS and Liga MX sides. Attendance figures are tracking closely with the 2024 edition, and organisers anticipate good crowds for Wednesday's games. The tournament's stakes are high, with automatic qualification for the Concacaf Champions Cup guaranteed for the winner of the third-place match and both finalists. The champion will secure direct entry into the Champions Cup Round of 16.

Trump has bought more than $100m in bonds while president, disclosure shows
Trump has bought more than $100m in bonds while president, disclosure shows

The Guardian

timean hour ago

  • The Guardian

Trump has bought more than $100m in bonds while president, disclosure shows

Donald Trump has bought more than $100m in company, state and municipal bonds since taking office in January, according to new disclosures which shed further light on the vast holdings of the US's billionaire president. The forms, posted online on Tuesday, show the Republican former real estate mogul made more than 600 financial purchases since 21 January, the day after he was inaugurated for his second term in the White House. The 12 August filing from the US Office of Government Ethics does not list exact amounts for each purchase, only giving a broad range. They include corporate bonds from Citigroup, Morgan Stanley and Wells Fargo, as well as Meta, Qualcomm, the Home Depot, T-Mobile USA and UnitedHealth Group. Other debt purchases include various bonds issued by cities, states, counties and school districts as well as gas districts, and other issuers. The holdings cover sectors that could benefit from US policy shifts under his administration, such as financial deregulation. A senior White House official said Trump continued to file mandatory disclosures about his investment portfolio but that neither he nor his family had a role in managing or selecting the bonds, which are managed by a third-party financial institution. Federal ethics officials certified the reports, which are in compliance with applicable laws, according to the official, who declined to be named. Trump, a businessperson turned politician, has said he has put his companies into a trust managed by his children. 'President Trump's net worth has increased substantially, with much of that concentrated in crypto holdings and Trump Media. Given that, there is no evidence currently that his bond purchases are anything other than a prudent diversification within his billions of dollars in assets,' said John Canavan, lead US analyst at Oxford Economics. 'It seems like he was primarily purchasing corporate and municipal bonds and others that are high quality and highly rated, so it's just a way to take a little bit of risk off the table,' he said. Trump's annual disclosure form filed in June showed his income from various sources still ultimately accrues to the president – something that has opened him up to accusations of conflicts of interest. In that disclosure, which appeared to cover the 2024 calendar year, Trump reported more than $600m in income from cryptocurrencies, golf properties, licensing and other ventures. It also showed his push into crypto had added substantially to his wealth. Overall, Trump reported assets worth at least $1.6bn, according to a Reuters calculation at the time.

Masimo sues US Customs over approval of Apple Watch imports
Masimo sues US Customs over approval of Apple Watch imports

Reuters

time2 hours ago

  • Reuters

Masimo sues US Customs over approval of Apple Watch imports

WASHINGTON, Aug 20 (Reuters) - Medical monitoring technology company Masimo (MASI.O), opens new tab sued U.S. Customs and Border Protection on Wednesday over a decision by the agency that allowed Apple (AAPL.O), opens new tab to import Apple Watches with blood-oxygen reading technology during a patent dispute between the companies. Masimo said in the lawsuit, opens new tab in Washington, D.C., federal court that Customs improperly determined that Apple can import watches with pulse oximetry technology, reversing its own decision from last year without notifying Masimo. Masimo told the court that it learned of the agency's August 1 decision only after Apple announced it would reintroduce blood-oxygen reading to its watches last week. Spokespeople for Apple and Customs did not immediately respond to requests for comment. A Masimo spokesperson declined to comment. Irvine, California-based Masimo has accused Apple of hiring away its employees and stealing its pulse oximetry technology to use in its Apple Watches. Masimo has separately sued Apple for patent infringement and trade secret theft in ongoing federal court cases. Masimo convinced the U.S. International Trade Commission to block imports of Apple's Series 9 and Ultra 2 smartwatches in 2023 based on a determination that Apple's technology for reading blood oxygen levels infringed Masimo's patents. Apple has continued to sell Customs-approved redesigned watches without pulse oximetry since the ITC's decision. Apple said on Aug. 14 that it would reintroduce its smartwatches' blood-oxygen reading capabilities with approval from Customs. Masimo said the agency's decision to approve the watches without input from Masimo or any "meaningful justification" deprived the company of its rights. "CBP's function is to enforce ITC exclusion orders, not to create loopholes that render them ineffective," Masimo said. Masimo asked the Washington court to halt the agency's ruling and continue to block Apple from selling watches with the blood-oxygen feature.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store